European Pharmacopoeia -ph. Eur.- Monograph Tablets -0478- [extra Quality] File

Promote fast breakdown upon contact with moisture.

Includes film-coated (disintegration < 30 min) and other coated types (disintegration < 60 min).

: For tablets with break-marks, the efficacy of the mark is assessed by weighing subdivided parts. Not more than one out of 30 parts may fall outside 85% to 115% of the average mass. 4. Mandatory Pharmacopoeial Tests European Pharmacopoeia -ph. Eur.- Monograph Tablets -0478-

: Including prolonged-release and delayed-release (gastro-resistant) forms to control where or when the drug is absorbed. Reference Standards

The Ph. Eur. actively works with other major pharmacopoeias (like the and Japanese Pharmacopoeia ) through the Pharmacopoeial Discussion Group (PDG) to harmonize standards wherever possible. This global harmonization is guided by principles such as those outlined in the ICH Q6A guideline on specifications, and it represents a continuous effort to align key tests like disintegration. Promote fast breakdown upon contact with moisture

This public link is valid for 7 days and shares a thread, including any personal information you added. This link or copies made by others cannot be deleted. If you share with third parties, their policies apply. Can’t copy the link right now. Try again later. Revised Ph. Eur. Chapter Tablets - gmp-compliance.org

This monograph is legally binding in all signatory states of the European Pharmacopoeia Convention and serves as the baseline for marketing authorization applications. or time of active substance release.

The active substance(s) must be identified using the tests prescribed in the specific monograph for that substance (e.g., spectroscopy, chromatography).

The serves as the definitive, legally binding regulatory standard for oral solid dosage forms manufactured, distributed, and marketed across Europe. Maintained by the European Directorate for the Quality of Medicines & HealthCare (EDQM) , this general dosage form monograph establishes the precise core definition, critical physical testing frameworks, manufacturing directives, and specialized subset criteria necessary to ensure uniform pharmaceutical quality and consumer safety. Core Definition and Material Composition

updated its policy to include specific dissolution or disintegration tests for all immediate-release solid dosage forms. Why It Matters EP – or Ph.Eur European Pharmacopeia - Kaye Instruments

: Expertly formulated with specific excipients or manufacturing steps to alter the rate, site, or time of active substance release.